Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (1999) | Total Docs. (3years) | Total Refs. (1999) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (1999) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 79 | Clin-Alert | journal | 0.100 Q4 | 0 | 0 | 69 | 0 | 0 | 69 | 0.00 | 0.00 |  |
| 78 | Pharmaceutical Chemistry Journal | journal | 0.101 Q4 | 39 | 176 | 514 | 3386 | 6 | 514 | 0.01 | 19.24 | |
| 77 | Drug Topics | journal | 0.107 Q4 | 8 | 502 | 1320 | 35 | 28 | 910 | 0.02 | 0.07 | |
| 76 | Research Communications in Pharmacology and Toxicology | journal | 0.109 Q4 | 8 | 20 | 41 | 465 | 10 | 41 | 0.24 | 23.25 | |
| 75 | Journal of Herbs, Spices and Medicinal Plants | journal | 0.122 Q4 | 34 | 10 | 127 | 192 | 19 | 125 | 0.09 | 19.20 | |
| 74 | U.S. Pharmacist | trade journal | 0.122 Q4 | 12 | 0 | 41 | 0 | 2 | 27 | 0.00 | 0.00 | |
| 73 | Pharmacopeial Forum (discontinued) | journal | 0.124 Q4 | 20 | 0 | 70 | 0 | 16 | 70 | 0.24 | 0.00 | |
| 72 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.126 Q4 | 29 | 11 | 28 | 879 | 5 | 26 | 0.15 | 79.91 | |
| 71 | Proceedings of the Western Pharmacology Society | journal | 0.140 Q3 | 25 | 119 | 347 | 803 | 46 | 346 | 0.14 | 6.75 | |
| 70 | Journal of Infectious Disease Pharmacotherapy | journal | 0.149 Q3 | 6 | 18 | 32 | 529 | 10 | 32 | 0.00 | 29.39 | |
| 69 | American Journal of Therapeutics | journal | 0.155 Q3 | 69 | 53 | 227 | 1371 | 65 | 219 | 0.34 | 25.87 | |
| 68 | Adverse Drug Reaction Bulletin | journal | 0.158 Q3 | 8 | 6 | 19 | 256 | 8 | 19 | 0.58 | 42.67 | |
| 67 | Hospital Pharmacy | journal | 0.159 Q3 | 28 | 158 | 478 | 1773 | 72 | 399 | 0.18 | 11.22 | |
| 66 | Journal of the American Pharmacists Association : JAPhA | journal | 0.199 Q3 | 73 | 110 | 299 | 624 | 116 | 270 | 0.42 | 5.67 | |
| 65 | Clinical Research and Regulatory Affairs | journal | 0.219 Q3 | 18 | 18 | 60 | 440 | 13 | 60 | 0.17 | 24.44 | |
| 64 | Drug and Chemical Toxicology | journal | 0.221 Q3 | 54 | 47 | 99 | 1097 | 54 | 98 | 0.40 | 23.34 | |
| 63 | Current Therapeutic Research | journal | 0.262 Q3 | 46 | 77 | 315 | 1420 | 167 | 296 | 0.59 | 18.44 | |
| 62 | American Journal of Health-System Pharmacy | journal | 0.277 Q3 | 107 | 494 | 1380 | 5867 | 699 | 883 | 0.53 | 11.88 | |
| 61 | Biologicals | journal | 0.278 Q3 | 66 | 61 | 157 | 769 | 120 | 153 | 0.78 | 12.61 | |
| 60 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.280 Q3 | 68 | 58 | 159 | 1859 | 106 | 141 | 0.76 | 32.05 | |
| 59 | Cardiovascular Drug Reviews | journal | 0.300 Q2 | 54 | 28 | 68 | 1342 | 52 | 68 | 0.96 | 47.93 | |
| 58 | Food and Drug Law Journal | journal | 0.306 Q2 | 23 | 48 | 155 | 4007 | 59 | 155 | 0.45 | 83.48 | |
| 57 | Pharmacological Research | journal | 0.308 Q2 | 169 | 147 | 450 | 4946 | 364 | 447 | 0.75 | 33.65 | |
| 56 | Prostaglandins and Other Lipid Mediators | journal | 0.330 Q2 | 86 | 59 | 333 | 1992 | 469 | 332 | 1.47 | 33.76 | |
| 55 | Journal of Experimental Therapeutics and Oncology | journal | 0.352 Q2 | 40 | 0 | 48 | 0 | 41 | 48 | 0.00 | 0.00 | |
| 54 | Journal of Pharmacological and Toxicological Methods | journal | 0.362 Q2 | 83 | 58 | 185 | 1582 | 157 | 184 | 0.88 | 27.28 | |
| 53 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.380 Q2 | 40 | 105 | 378 | 2389 | 332 | 378 | 0.85 | 22.75 | |
| 52 | Medical Letter on Drugs and Therapeutics | journal | 0.400 Q2 | 22 | 55 | 169 | 0 | 163 | 165 | 1.11 | 0.00 | |
| 51 | Addiction Biology | journal | 0.421 Q2 | 93 | 47 | 119 | 1993 | 128 | 117 | 1.14 | 42.40 | |
| 50 | Drug Development and Industrial Pharmacy | journal | 0.426 Q2 | 100 | 172 | 463 | 2835 | 284 | 461 | 0.63 | 16.48 | |
| 49 | CNS Drug Reviews | journal | 0.457 Q2 | 64 | 48 | 74 | 1513 | 86 | 74 | 0.69 | 31.52 | |
| 48 | Metal-Based Drugs | journal | 0.474 Q2 | 40 | 47 | 106 | 1303 | 110 | 105 | 1.03 | 27.72 | |
| 47 | Journal of Biopharmaceutical Statistics | journal | 0.477 Q2 | 56 | 42 | 127 | 705 | 61 | 122 | 0.50 | 16.79 | |
| 46 | Anti-Cancer Drugs | journal | 0.496 Q2 | 102 | 127 | 418 | 3493 | 725 | 410 | 1.83 | 27.50 | |
| 45 | Basic and Clinical Pharmacology and Toxicology | journal | 0.510 Q2 | 103 | 106 | 347 | 3874 | 427 | 344 | 1.11 | 36.55 | |
| 44 | Vascular Pharmacology | journal | 0.518 Q2 | 108 | 163 | 749 | 5521 | 894 | 746 | 1.17 | 33.87 | |
| 43 | Clinical Therapeutics | journal | 0.550 Q2 | 150 | 187 | 406 | 5437 | 744 | 357 | 1.92 | 29.07 | |
| 42 | Journal of Ocular Pharmacology and Therapeutics | journal | 0.578 Q2 | 72 | 59 | 170 | 1447 | 169 | 169 | 0.87 | 24.53 | |
| 41 | Journal of Clinical Pharmacology | journal | 0.611 Q2 | 130 | 157 | 461 | 4251 | 818 | 447 | 1.77 | 27.08 | |
| 40 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 0.632 Q2 | 150 | 96 | 275 | 3693 | 397 | 274 | 1.49 | 38.47 | |
| 39 | Drug Resistance Updates | journal | 0.642 Q2 | 132 | 51 | 56 | 3305 | 109 | 48 | 1.95 | 64.80 | |
| 38 | Journal of Cardiovascular Pharmacology | journal | 0.648 Q2 | 109 | 290 | 1023 | 9704 | 1608 | 1016 | 1.48 | 33.46 | |
| 37 | Therapeutic Drug Monitoring | journal | 0.660 Q1 | 102 | 105 | 372 | 2061 | 541 | 352 | 1.36 | 19.63 | |
| 36 | Clinical Neuropharmacology | journal | 0.672 Q1 | 85 | 65 | 197 | 2155 | 419 | 187 | 1.91 | 33.15 | |
| 35 | Bulletin of Mathematical Biology | journal | 0.702 Q1 | 97 | 49 | 147 | 1824 | 169 | 147 | 1.18 | 37.22 | |
| 34 | Chirality | journal | 0.707 Q1 | 83 | 124 | 307 | 2883 | 461 | 303 | 1.36 | 23.25 | |
| 33 | Experimental and Clinical Psychopharmacology | journal | 0.719 Q1 | 101 | 53 | 143 | 2565 | 240 | 143 | 1.43 | 48.40 | |
| 32 | Anti-Cancer Drug Design | journal | 0.802 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 31 | Journal of Pharmacokinetics and Pharmacodynamics | journal | 0.820 Q1 | 70 | 32 | 108 | 792 | 202 | 103 | 1.12 | 24.75 | |
| 30 | Steroids | journal | 0.827 Q1 | 114 | 109 | 322 | 3538 | 725 | 320 | 2.50 | 32.46 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data